Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
Carosi
G
G
Castelli
F
F
Lernestedt
J O
JO
Antoniazzi
E
E
Gerna
G
G
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D017245:Foscarnet / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011446:Prospective Studies
D000998:Antiviral Agents; D017245:Foscarnet